Aveanna Healthcare (NASDAQ:AVAH) Insider Edwin Reisz Sells 16,755 Shares

by · The Cerbat Gem

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) insider Edwin Reisz sold 16,755 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total transaction of $140,071.80. Following the completion of the sale, the insider directly owned 1,355,329 shares of the company’s stock, valued at $11,330,550.44. This represents a 1.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded down $0.09 during trading hours on Friday, hitting $8.08. 2,526,966 shares of the stock traded hands, compared to its average volume of 1,076,101. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32. The stock has a 50 day moving average price of $8.92 and a 200 day moving average price of $7.49. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The firm had revenue of $450.53 million during the quarter. Sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on AVAH shares. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their price objective for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. BMO Capital Markets started coverage on Aveanna Healthcare in a report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target on the stock. Jefferies Financial Group upped their price target on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday. Finally, William Blair initiated coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating for the company. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $10.69.

Get Our Latest Report on AVAH

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Summit Partners L P purchased a new stake in Aveanna Healthcare during the second quarter valued at $50,477,000. Vanguard Group Inc. grew its stake in shares of Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after buying an additional 1,041,324 shares in the last quarter. AustralianSuper Pty Ltd purchased a new position in shares of Aveanna Healthcare in the 3rd quarter worth $15,743,000. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Aveanna Healthcare by 70.1% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock worth $10,031,000 after buying an additional 466,022 shares during the last quarter. Finally, Algert Global LLC raised its position in shares of Aveanna Healthcare by 120.1% during the 3rd quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after buying an additional 557,898 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Read More